These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1007978)
1. [Neurochemical and pharmacological principles in the therapy of epilepsies]. Cotrufo R; Bonavita V Acta Neurol (Napoli); 1976; 31(2):131-45. PubMed ID: 1007978 [No Abstract] [Full Text] [Related]
2. [Experimental models of epilepsy]. Fernández Guardiola A; Tapia R; Brailowsky S; Rodríguez R; Luján M; Ramírez R; Medina M; Capistrán C; Calvo JM; Rocha L Gac Med Mex; 1992; 128(4):443-60. PubMed ID: 1364042 [No Abstract] [Full Text] [Related]
3. [Neurotransmitters and epilepsy. The antiepileptic effect of biogenic amines gamma-aminobutyric-acid and taurine in patients with epilepsy (author's transl)]. Schmidt D Nervenarzt; 1980 Oct; 51(10):582-90. PubMed ID: 6109260 [No Abstract] [Full Text] [Related]
4. [GABA receptor complex and the mechanisms of action of various anticonvulsants (review of the literature)]. Aksent'ev SB; Levinskiĭ MV Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):136-46. PubMed ID: 2158715 [No Abstract] [Full Text] [Related]
5. [GABAergic theory of epilepsy]. Lloyd KG Rev Prat; 1986 Jan; 36(5):243-54. PubMed ID: 3008304 [No Abstract] [Full Text] [Related]
8. [Mechanism of action of antiepileptic drugs and new antiepileptic drugs]. Armijo JA; Adin J; Sánchez MB Rev Neurol; 2006 Oct; 43 Suppl 1():S17-41. PubMed ID: 17061186 [TBL] [Abstract][Full Text] [Related]
9. [Anticonvulsive drug therapy. Historical and current aspects]. Bauer J; Elger CE Nervenarzt; 1995 Jun; 66(6):403-11. PubMed ID: 7543658 [TBL] [Abstract][Full Text] [Related]
10. Handling seizure data: special problems. Pierce MW; Shu VS Epilepsy Res Suppl; 1993; 10():175-8. PubMed ID: 8251093 [No Abstract] [Full Text] [Related]
11. [Molecular structures of anticonvulsants: molecular neurobiology of epilepsy]. Böhme I; Lüddens H Pharm Unserer Zeit; 2007; 36(4):262-8. PubMed ID: 17623315 [No Abstract] [Full Text] [Related]
12. Extractum belladonnae as an adjuvant to luminal in the therapy of epilepsy with a possible explanation in neurophysiological and neurochemical terms. Sie PG Proc Aust Assoc Neurol; 1968; 5(1):113-9. PubMed ID: 4974640 [No Abstract] [Full Text] [Related]
13. Use of animal models in developing guiding principles for polypharmacy in epilepsy. Löscher W; Wauquier A Epilepsy Res Suppl; 1996; 11():61-5. PubMed ID: 9294728 [No Abstract] [Full Text] [Related]
14. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Remy S; Beck H Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026 [TBL] [Abstract][Full Text] [Related]
15. Anticonvulsants in epileptic fowl. Johnson DD; Davis HL Arzneimittelforschung; 1984; 34(12):1753-7. PubMed ID: 6543309 [TBL] [Abstract][Full Text] [Related]
18. Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy. Gernert M; Fedrowitz M; Wlaz P; Löscher W Eur J Neurosci; 2004 Nov; 20(9):2377-86. PubMed ID: 15525279 [TBL] [Abstract][Full Text] [Related]
19. Scope and contribution of genetic models to an understanding of the epilepsies. Jobe PC; Mishra PK; Ludvig N; Dailey JW Crit Rev Neurobiol; 1991; 6(3):183-220. PubMed ID: 1773452 [TBL] [Abstract][Full Text] [Related]
20. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy. Löscher W; Ebert U Epilepsy Res Suppl; 1996; 11():17-43. PubMed ID: 9294726 [No Abstract] [Full Text] [Related] [Next] [New Search]